ABBOTT LABORATORIES (ABL.DE) Stock Income Statement
FRA:ABL • US0028241000
Current stock price
82.54 EUR
+0.66 (+0.81%)
Last:
| TTM (2026-3-31) | 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 45.13B | 44.33B | 41.95B | 40.11B | 43.65B | |||
| Cost Of Goods | 19.64B | 19.21B | 18.64B | 17.92B | 19.08B | |||
| Gross Profit | 25.50B | 25.12B | 23.31B | 22.19B | 24.57B | |||
| Operating Expenses | 17.05B | 16.79B | 16.31B | 15.47B | 15.86B | |||
| Research and Development | 2.93B | 2.89B | 2.78B | 2.62B | 2.74B | |||
| Selling, General, and Administrative Expenses | 12.43B | 12.22B | 11.65B | 10.88B | 11.11B | |||
| Operating Income | 8.45B | 8.33B | 6.99B | 6.72B | 8.71B | |||
| Interest Income/Expense | -148.00M | -135.00M | -188.00M | -293.00M | -377.00M | |||
| Other Income/Expense | 573.00M | 548.00M | 558.00M | 518.00M | 366.00M | |||
| Non Recurring Items | -740.00M | -274.00M | -350.00M | -283.00M | -390.00M | |||
| Income Before Taxes | 8.14B | 8.47B | 7.01B | 6.66B | 8.31B | |||
| Income Tax | 1.86B | 1.94B | -6.39B | 941.00M | 1.37B | |||
| Net Income | 6.28B | 6.52B | 13.40B | 5.72B | 6.93B | |||
| EBITDA | N/A | 11.44B | 10.21B | 9.96B | 11.97B | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 3.60 | 3.73 | 7.67 | 3.27 | 3.93 | |||
| Non GAAP EPS | 5.21 | 5.15 | 4.67 | 4.44 | 5.34 | |||
| Statistics | ||||||||
| Gross Profit Margin | 56.50% | 56.66% | 55.56% | 55.32% | 56.28% | |||
| Profit Margin | 13.91% | 14.72% | 31.95% | 14.27% | 15.88% | |||
| Operating Profit Margin | 18.73% | 18.78% | 16.67% | 16.76% | 19.95% | |||
All data in USD